Romark, Roche deal

Roche's Chugai Pharmaceutical Co. Ltd. subsidiary received exclusive rights to develop and commercialize Romark's Alinia nitazoxanide in Japan. The nitrothiazolyl-salicylamide compound is in Phase I...